PODD Conference | Home Page

Networking

Where drug delivery leaders come together

Pharma, biotech and drug delivery industries will gather at the 16th annual PODD: Partnership Opportunities in Drug Delivery conference to assess delivery needs, explore partnership opportunities, and stay at the forefront of innovative drug delivery technologies. This includes small molecules, biologics, combination products, connected devices, cell and gene delivery and more.

PODD provides partnering opportunities through organized networking for new, emerging and established collaborations.

2026 Keynotes

Robert Langer, ScD

David H Koch Institute Professor

MIT

George Yancopoulos, MD, PhD

Board Co-Chair, President and Chief Scientific Officer

Regeneron

Sabrena Gates

Head of Clinical Project Management-Rare Diseases

Chiesi USA

Pavlos Vlachos, PhD

SVP, Device Delivery & Connected Solutions

Eli Lilly and Company

Must Attend Sessions

Industry Leaders Speaking at PODD

Sherri Biondi, PhD

Executive Director, Device Development

AstraZeneca

Beate Bittner, PhD

Head Product Optimization

Roche

Clare Beddoes, PhD

Head of Drug Delivery

Cambridge Design Partnership

Shiv Krishnan, PhD

VP, Global Search & Evaluation – Early Stage, Global Business Development,

Daiichi Sankyo

Elena Diez Cecilia, PhD, MBA

Senior Director External Innovation DPDS

Johnson & Johnson Innovative Medicine

Takayuki Yoshida, PhD

Senior Director, Head of DDS

Astellas Pharma

Jamie Tsung, PhD

Director, Head of DP Formulation, CMC Development

Alnylam Pharmaceuticals

Stephen Fournier

Head Global Drug Delivery Systems

CSL Behring

Annette Bak, PhD, MBA

Head of New Modality Product Discovery & Development

AstraZeneca

Ester Caffarel-Salvador, PhD

Director, Strategic Innovation, Global Rare Diseases

Chiesi USA

Sudhakar Garad, PhD

Global Head of Chemical and Pharmaceutical Profiling

Novartis

Mark DeStefano

Senior Director, Global Technology Innovation, Combination Products and Device R&D

Teva Pharmaceuticals

Monica Swinney, PhD

Industry Expert in Drug Delivery Innovation, formerly Head of Innovation & New Product Planning

Gilead Sciences

Suzette Roan

Head of Regulatory Affairs Device, Global R&D

Sanofi

Srini Sridharan, PhD

Executive Director, Drug Delivery & Product Integration

BMS

See Who's Speaking

2026 Drug Delivery Technology Track Options

Injectable Formulations & Technologies

Oral, Nasal, Pulmonary & Other Non-Injectable Technologies

Novel Devices: Self-Injectables, Wearables & Connected Devices

Cell, Gene & Novel Biologics Delivery

Novel Materials & Excipient Innovation

Novel Device Technologies

Novel Injectable & Non-Injectable Technologies

Self-Injection Devices, Syringes, Primary Container & Packaging Solutions

Additional Program Benefits

The PODD Promise

PODD Multimedia Content